GT Biopharma, Inc.

New Filing
CIK: 0000109657·Biotechnology·FLORIDA·Filed: Feb 6, 2018
Total Offering

$7,055,000

Amount Sold

$7,055,000

Investors

14

First Sale

Jan 23, 2018

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Steven Weldon
Related Person
Anthony J. Cataldo
Related Person
Kathleen Clarence-Smith
Related Person
Geoffrey B. Davis
Related Person

Company

GT Biopharma, Inc.

1825 K Street, Suite 510

Washington, DC, 20006

800-304-9888

SEC Filing

0001654954-18-001133

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free